Methods A retrospective, observational, cohort study of antiretroviral therapy-naive adult HIV-positive patients starting an initial cART including raltegravir (RAL), dolutegravir (DTG), elvitegravir鈥揷obicistat (EVG), or DRV/r. We compared changes in weight and body mass index (BMI) across the...
Gish RG, Nelson D, Arora S, Fried MW, Reddy KR, Xu Y, Murphy B (2005) Virologic response and safety outcomes in therapy-naive patients treated for chronic hepatitis C with viramidine in combination with pegylated interferon alfa-2a. J Hepatol 42(Suppl 2):39A...
Saurabh Agrawal, Paul Y. Kwo. (2012) The new standard of HCV therapy: Treatment in therapy-naive patients. Clinical Liver Disease 1 , 12-15 /SaurabhAgrawal, Paul Y.Kwo. (2012) The new standard of HCV therapy: Treatment in therapy-naive patients. Clinical Liver Disease 1 , 12-15 /...
There are nodata comparing neuropsychological function by HIV subtype in Ugandan children.Design: One hundred and two HIV-infected antiretroviral therapy (ART) naiveUgandan children 6–12 years old (mean 8.9) completed the Kaufman AssessmentBattery for Children, second edition (KABC-2), the Test ...
HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HI... HLA-DQB1*06 and breadth of Nef core region- specific T-cell response are associated with slow disease progression in antiretroviral ...
The NEAT Study: GW433908 Efficacy and Safety in Antiretroviral Therapy-Naive SubjectsCoverage provided by
Association of Specific Comorbidities with Monosodium Urate Crystal Deposition in Urate-Lowering Therapy-Naive Gout Patients: A Cross-Sectional Dual-Energy Computed Tomography Study(1) Background: To determine which factors are associated with the volume of monosodium urate (MSU) crystal deposition ...
2012. Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients. J Viral Hepat 19:39 - 46. http://dx.doi.org/10.1111/j.1365-2893.2010.01399.x.
Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the ... - 《Jaids Journal of Acquired Immune Deficiency Syndromes》 被引量: 0发表: 2016年 Dolutegravir plus Abacavir–Lamivudine for the Treatment ...
Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the ... Brief report: dolutegravir plus abacavir/lamivudine for the treatment of HIV-1 infection in antiretroviral therapy-naive patients: week 96 ...